Home Monitoring in Delaware

Pelegon LLC is a US-based medical mobility and home care solutions provider specializing in assistive devices and safety equipment for seniors, post-surgical recovery, and daily living support. The company designs and markets a comprehensive range of mobility aids, bathroom safety solutions, and recovery products including rollator walkers, toilet safety rails, shower chairs, raised toilet seats, transfer benches, and ice pack therapy wraps. Products feature weight capacity ratings (350–450 lbs), adjustable designs, and durable construction targeted at independent and assisted living scenarios. The company operates a direct-to-consumer e-commerce model with offerings including product bundles for specific recovery needs such as hip/knee replacement, post-surgery support, and general fall prevention. Pelegon emphasizes customer service with a 3-year warranty, hassle-free returns, free US shipping on orders over $75, and FSA/HSA eligibility on products. The company maintains an active customer review presence on Trustpilot with strong ratings and publishes educational content via a product blog covering senior safety, caregiver guidance, and mobility best practices. Manufacturing and quality standards are described as meeting engineering precision and highest standards, though specific FDA, ISO, or regulatory certifications are not detailed on the public website.

Neteera Technologies Ltd. is an FDA-cleared healthcare technology company specializing in contactless remote patient monitoring (RPM) using sub-THz micro-radar on-chip sensors. The company's primary offering is the Neteera System, a ceiling- or wall-mounted device that passively measures vital signs and biomarkers without wearables, cameras, or patient interaction. The system continuously monitors heart rate and pattern analysis, respiratory rate and depth, inhale/exhale ratio, sleep analysis, position changes, motion, and occupancy/exit detection. Designed for use across health systems, hospitals, medical groups, payers, post-acute care facilities, and senior living communities, the technology enables proactive care, early detection of deterioration, and treat-in-place interventions. With over 30,000 deployed devices across 450+ care settings and proven capability to identify cardiac and respiratory events days in advance, Neteera's solution reduces alert fatigue, improves patient compliance, and supports workflow optimization. The system is ISO 13485-certified, HIPAA/HITECH/GDPR compliant, and SOC 2 Type II certified, positioning it as a comprehensive digital health platform for aging populations and clinical monitoring.

Nanodropper manufactures an FDA-listed, volume-reducing adaptor for eyedrop bottles designed to reduce drop size by over 60%, minimizing medication waste and reducing patient costs. The device twists onto compatible eyedrop bottles and addresses a critical clinical and economic issue: standard eyedrop bottles dispense approximately five times the volume the human eye can absorb, with up to 80% of each drop wasted through overflow or tear-duct drainage. Clinical research demonstrates that smaller drops are therapeutically equivalent to standard drops while reducing systemic side effects and improving patient adherence. The Nanodropper extends medication bottle life, allowing patients to achieve 5–6 weeks of therapy from single bottles normally depleted in 2–3 weeks, resulting in significant cost savings for expensive prescription ophthalmologic medications such as glaucoma treatments (some exceeding $300 per bottle). The device is compatible with most standard eyedrop bottles in two sizes and includes patient onboarding webinars and outcome-tracking surveys to validate therapeutic efficacy and cost impact. The company has received recognition from ProPublica, the American Academy of Ophthalmology, Mayo Clinic, and the U.S. Air Force, and has published clinical data supporting efficacy and safety. Target markets include glaucoma patients, dry-eye disease patients, and ophthalmology/optometry practices seeking to improve medication access and patient compliance.